These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 102205)

  • 1. Genetic control of resistance to tumors.
    Phillips-Quagliata JM; Walker MC
    Am J Pathol; 1978 Nov; 93(2):487-98. PubMed ID: 102205
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hybrid resistance to BALB/c plasmacytomas: F1 hybrid anti-MPC-11 immunological responses correlated with resistance to tumor challenge.
    Marsili MA; Walker MC; Phillips-Quagliata JM
    Cancer Res; 1986 Jan; 46(1):190-7. PubMed ID: 3484380
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hybrid resistance to BALB/c plasmacytomas. I. Resistance to MPC-11 controlled by a locus not linked to H-2.
    Walker MC; Phillips-Quagliata JM
    J Immunol; 1979 Apr; 122(4):1535-43. PubMed ID: 448097
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetics of resistance to the African trypanosomes. VI. Heredity of resistance and variable surface glycoprotein-specific immune responses.
    De Gee AL; Levine RF; Mansfield JM
    J Immunol; 1988 Jan; 140(1):283-8. PubMed ID: 3121739
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hybrid resistance to BALB/c plasmacytomas. II. Radiation sensitivity and silica insensitivity of resistance to MPC-11.
    Walker MC; Phillips-Quagliata JM
    J Immunol; 1979 Apr; 122(4):1544-7. PubMed ID: 221576
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor immunity to murine plasma cell tumors. V. Genetic control of the in vitro cytotoxic T-cell response to plasma cell tumor-associated antigens of NZB mice.
    Burton RC; Warner NL
    J Natl Cancer Inst; 1980 Aug; 65(2):431-40. PubMed ID: 6967529
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction of tumor-specific antitumor immunity after chemotherapy with cisplatin in mice bearing MOPC-104E plasmacytoma by modulation of MHC expression on tumor surface.
    Nio Y; Hirahara N; Minari Y; Iguchi C; Yamasawa K; Toga T; Tamura K
    Anticancer Res; 2000; 20(5A):3293-9. PubMed ID: 11062756
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of the major histocompatibility complex loci and T-cell receptor beta-chain repertoire on Theiler's virus-induced demyelinating disease.
    Kim BS; Mohindru M; Kang B; Kang HS; Palma JP
    J Neurosci Res; 2005 Sep; 81(6):846-56. PubMed ID: 16049971
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro and in vivo correlates of hybrid tumor resistance.
    Stuart PM; Iannaccone PM; Miller SD; Jenkins MK; Del Muro FA; Melvold RW
    J Natl Cancer Inst; 1987 Jun; 78(6):1159-68. PubMed ID: 3495687
    [TBL] [Abstract][Full Text] [Related]  

  • 10. H-40, an antigen controlled by an Igh-linked gene and recognized by cytotoxic T lymphocytes. II. Recognition of H-40 as a tumor antigen in leukemic animals.
    Henderson LA; Ciavarra R; Riblet R; Forman J
    J Immunol; 1984 Nov; 133(5):2778-85. PubMed ID: 6434638
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-class II antibodies, but not cytotoxic T-lymphocyte antigen 4-immunoglobulin hybrid molecules, prevent rejection of major histocompatibility complex class II-negative myeloma in T-cell receptor-transgenic mice.
    Dembic Z; Hofgaard PO; Omholt H; Bogen B
    Scand J Immunol; 2004; 60(1-2):143-52. PubMed ID: 15238083
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunogenetic studies on the resistance of mice to highly metastatic DBA/2 tumor cell variants. I. Effect of incompatibilities at H-2 or non-H-2 genes in normal and nude (nu/nu) mice.
    Schirrmacher V
    Invasion Metastasis; 1981; 1(1):4-21. PubMed ID: 7188381
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of the in vitro presentation of minor lymphocyte stimulating determinants by major histocompatibility complex-encoded immune response genes.
    Ryan JJ; Miner DW; Mond JJ; Finkelman FD; Woody JN
    J Immunol; 1987 Apr; 138(8):2392-401. PubMed ID: 2435797
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential tumor immunogenicity of DBA/2 mouse lymphoma L1210 and its sublines. III. Control of host resistance to drug-resistant L1210 sublines by H-2-linked and non-H-2-linked genes.
    Fuji H; Murakami M
    J Natl Cancer Inst; 1983 Jan; 70(1):119-25. PubMed ID: 6296515
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic control of the resistance to spontaneous immunocytoma (plasmacytoma-IR tumour) development in LOU/C rats.
    Bazin H; Kints JP; Rousseaux J
    Anticancer Res; 1986; 6(1):45-8. PubMed ID: 3954329
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immune responses to complex protein antigens I. MHC control of immune responses to bovine albumin.
    Riley RL; Wilson LD; Germain RN; Benjamin DC
    J Immunol; 1982 Oct; 129(4):1553-8. PubMed ID: 6180016
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ontogeny of MHC-linked, T cell-mediated suppression is regulated by the T cell genotype.
    Araneo BA
    J Mol Cell Immunol; 1986; 2(4):219-31. PubMed ID: 2855403
    [TBL] [Abstract][Full Text] [Related]  

  • 18. H-2D-associated hybrid resistance to EL4.
    Harmon RC; Clark EA; Klein J; Hildemann WH
    Transplant Proc; 1979 Jun; 11(2):1353-4. PubMed ID: 112738
    [No Abstract]   [Full Text] [Related]  

  • 19. Genetic control of the immune response to ferredoxin: linkage and mapping of T cell proliferation and antibody production genes to the MHC of mice.
    Sikora LK; Levy JG
    J Immunol; 1980 Jun; 124(6):2615-9. PubMed ID: 6768798
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic regulation of the immune response to hepatitis B surface antigen (HBsAg). I. H-2 restriction of the murine humoral immune response to the a and d determinants of HBsAg.
    Milich DR; Chisari FV
    J Immunol; 1982 Jul; 129(1):320-5. PubMed ID: 6177755
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.